Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
4.610
-0.290 (-5.92%)
At close: Nov 7, 2025, 4:00 PM EST
4.570
-0.040 (-0.87%)
After-hours: Nov 7, 2025, 4:21 PM EST
Lyra Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lyra Therapeutics stock has a target of 16, which predicts a 247.07% increase from the current stock price of 4.61.
Price Target: $16 (+247.07%)
Analyst Consensus: Hold
* Price targets were last updated on Aug 14, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Lyra Therapeutics is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 3 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $16 | Hold | Reiterates | $16 | +247.07% | Aug 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $2 → $16 | Hold | Maintains | $2 → $16 | +247.07% | Jun 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $100 | Hold | Reiterates | $100 | +2,069.20% | Mar 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $100 | Hold | Reiterates | $100 | +2,069.20% | Aug 15, 2024 |
Financial Forecast
Revenue This Year
774.69K
from 1.53M
Decreased by -49.50%
Revenue Next Year
1.60M
from 774.69K
Increased by 106.28%
EPS This Year
-19.69
from -71.75
EPS Next Year
-9.79
from -19.69
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.6M | 4.2M | |||
| Avg | 774,690 | 1.6M | |||
| Low | 392,000 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.7% | 442.2% | |||
| Avg | -49.5% | 106.3% | |||
| Low | -74.4% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -11.82 | -6.57 | |
| Avg | -19.69 | -9.79 | |
| Low | -25.15 | -15.19 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.